Literature DB >> 10743538

Potential role of lactobacilli as prophylactic agents against genital pathogens.

C Barbés1, S Boris.   

Abstract

The characteristics required of lactobacilli as probioties are the following: beneficial function, easy cultivation, nonpathogenicity, adhesion, and population stability. Several studies have assessed the potential of lactobacilli in the prevention or treatment of certain genitourinary tract infections such as bacterial vaginosis, vaginitis, or urinary tract infections. The main goal of therapy with biotherapeutic agents should be to prevent overgrowth of a pathogen until such a time that the normal microbiota can be reestablished. The possibility of using lactobacilli is promising, especially in pregnant women and in the case of patients with recurrent genitourinary tract infections produced by strains with resistance to several antibiotics. In addition, probiotic therapy is considered as "natural" and without side effects in contrast with conventional pharmaceutical treatments, but there is a limited array of tested biotherapeutic agents and a lack of pharmacokinetic data.

Entities:  

Mesh:

Year:  1999        PMID: 10743538     DOI: 10.1089/apc.1999.13.747

Source DB:  PubMed          Journal:  AIDS Patient Care STDS        ISSN: 1087-2914            Impact factor:   5.078


  13 in total

1.  Persistence of Lactobacillus fermentum RC-14 and Lactobacillus rhamnosus GR-1 but not L. rhamnosus GG in the human vagina as demonstrated by randomly amplified polymorphic DNA.

Authors:  Gillian E Gardiner; Christine Heinemann; Andrew W Bruce; Dee Beuerman; Gregor Reid
Journal:  Clin Diagn Lab Immunol       Date:  2002-01

2.  Role of Vaginal Flora As a Barrier to HIV Acquisition.

Authors:  Jane R. Schwebke
Journal:  Curr Infect Dis Rep       Date:  2001-04       Impact factor: 3.725

Review 3.  Probiotics and medical nutrition therapy.

Authors:  Amy C Brown; Ana Valiere
Journal:  Nutr Clin Care       Date:  2004 Apr-Jun

Review 4.  Potential uses of probiotics in clinical practice.

Authors:  Gregor Reid; Jana Jass; M Tom Sebulsky; John K McCormick
Journal:  Clin Microbiol Rev       Date:  2003-10       Impact factor: 26.132

5.  Human immunodeficiency virus type 1 is trapped by acidic but not by neutralized human cervicovaginal mucus.

Authors:  Samuel K Lai; Kaoru Hida; Shetha Shukair; Ying-Ying Wang; Anna Figueiredo; Richard Cone; Thomas J Hope; Justin Hanes
Journal:  J Virol       Date:  2009-08-19       Impact factor: 5.103

Review 6.  Use of lactobacilli and estriol combination in the treatment of disturbed vaginal ecosystem: a review.

Authors:  Cihat Unlü; Gilbert Donders
Journal:  J Turk Ger Gynecol Assoc       Date:  2011-12-01

7.  Throwing the dice for the diagnosis of vaginal complaints?

Authors:  Andreas Schwiertz; David Taras; Kerstin Rusch; Volker Rusch
Journal:  Ann Clin Microbiol Antimicrob       Date:  2006-02-17       Impact factor: 3.944

8.  Investigation of vaginal microbiota in sexually active women using hormonal contraceptives in Pakistan.

Authors:  Yasmeen Faiz Kazi; Sobia Saleem; Nasreen Kazi
Journal:  BMC Urol       Date:  2012-08-18       Impact factor: 2.264

9.  Biomedical applications of fermenticin HV6b isolated from Lactobacillus fermentum HV6b MTCC10770.

Authors:  Baljinder Kaur; Praveen P Balgir; Bharti Mittu; Balvir Kumar; Neena Garg
Journal:  Biomed Res Int       Date:  2013-07-29       Impact factor: 3.411

Review 10.  Use of locally delivered dequalinium chloride in the treatment of vaginal infections: a review.

Authors:  Werner Mendling; Ernst Rainer Weissenbacher; Stefan Gerber; Valdas Prasauskas; Philipp Grob
Journal:  Arch Gynecol Obstet       Date:  2015-10-27       Impact factor: 2.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.